- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07536945
Individualized Care Perceptions of Patients Receiving Outpatient Chemotherapy: A Qualitative Study
The purpose of this observational study is to learn how people receiving chemotherapy in a clinic without staying overnight (outpatient) feel about the care they receive. The study focuses on individualized care, which means nursing care that is tailored specifically to each person's unique needs, values, and lifestyle.
Background:
Cancer treatment often involves chemotherapy (medicine used to kill cancer cells). While these treatments help fight the disease, they can also cause side effects like nausea or tiredness, which affect daily life. Nurses play a key role in helping people manage these effects. This research aims to understand how "individualized care" helps participants feel valued and supported during their treatment journey.
The study aims to answer these key questions:
How do participants describe their experiences with nursing care?
What are the specific needs and expectations of these individuals for care that feels personal to them?
How does personalized care affect their ability to manage symptoms and follow their treatment plan?
Scope and Setting:
This study will take place at the Yalova Training and Research Hospital within the Outpatient Chemotherapy Unit. The research will be conducted between May 1, 2026, and April 1, 2027.
Method and Participants:
The researchers plan to interview 10 to 20 participants who are over 18 years old and receiving treatment at the clinic. The final number of participants will be decided when the researchers find that no new information or themes are being discovered in the interviews (a stage called "data saturation").
Participants will:
Take part in a private, one-on-one interview with a researcher.
Answer open-ended questions about their thoughts and feelings regarding their nursing care.
Allow the interview to be voice-recorded to ensure all information is captured accurately.
Spend approximately 30 to 45 minutes sharing their personal experiences.
Privacy and Ethics:
Participant privacy is a top priority. All personal information and voice recordings will be kept strictly confidential. In the final report, fake names (aliases) will be used so that no one can be identified. Participants can choose to leave the study at any time. The study follows international ethical rules to protect the rights of every participant.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Seyda CAN, Assoc. Prof.
- Phone Number: +905366850312
- Email: seyda.can@yalova.edu.tr
Study Contact Backup
- Name: Yasemin KARA OKMEN, BSc
- Phone Number: +905469218182
- Email: yaseminkara37@hotmail.com
Study Locations
-
-
Yalova
-
Yalova, Yalova, Turkey (Türkiye), 77200
- University of Yalova
-
Contact:
- Seyda CAN, Assoc. Prof.
- Phone Number: +905366850312
- Email: seyda.can@yalova.edu.tr
-
Contact:
- Yasemin KARA OKMEN, BSc
- Phone Number: +905469218182
- Email: yaseminkara37@hotmail.com
-
Principal Investigator:
- Seyda CAN, Assoc. Prof.
-
Sub-Investigator:
- Yasemin KARA OKMEN, BSc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Continuing treatment at the Outpatient Chemotherapy Unit of the relevant hospital.
- Voluntarily agreeing to participate in the study.
- Being over 18 years of age.
- Being proficient in Turkish.
- Exclusion Criteria:
- Not receiving ongoing treatment at the Outpatient Chemotherapy Unit of the relevant hospital.
- Declining to participate in the study voluntarily.
- Unwillingness to answer questions or lack of cooperation during the interview.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants expressing specific themes regarding perceptions of individualized nursing care.
Time Frame: Through study completion (approximately 12 months).
|
This outcome measures the frequency and depth of perceptions of individualized nursing care as shared by participants during semi-structured interviews.
Data will be analyzed using descriptive and thematic analysis.
The results will be reported as the identified themes and the number of participants who expressed each specific theme or perception.
|
Through study completion (approximately 12 months).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants identifying specific categories of individualized nursing care needs and expectations.
Time Frame: Through study completion (approximately 12 months).
|
Through semi-structured interviews, participants will describe their specific nursing care needs and expectations.
Data will be analyzed to identify common categories of needs.
Results will be reported as a list of identified care need categories and the number of participants who expressed each specific need or expectation.
|
Through study completion (approximately 12 months).
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Yildirim, A., & Simsek, H. (2016). Qualitative Research Methods in the Social Sciences (Sosyal Bilimlerde Nitel Arastirma Yontemleri). Seckin Publishing.
- Palese, A., Tomietto, M., Suhonen, R., et al. (2011). Surgical patient satisfaction as an outcome of nurses' caring behaviours: A descriptive and correlational study in six European countries. Journal of Nursing Scholarship, 43(4), 341-350.
- Pekmezci, H., Köse, B. G., & Akbal, Y. (2024). Nursing care from the perspective of cancer patients. Journal of Nursology, 27(2), 146-152.
- Acaroğlu, R., Suhonen, R., Şendir, M., & Kaya, H. (2010). Reliability and validity of Turkish version of the individualised care scale. Journal of Clinical Nursing, 20(1-2), 136-145.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2026/123
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chemotherapy
-
Hospices Civils de LyonCompletedChemotherapy Effect | G-CHOP Chemotherapy | R-CHOP ChemotherapyFrance
-
Second Affiliated Hospital, School of Medicine,...RecruitingChemotherapy | Postoperative ChemotherapyChina
-
Applied Biology, Inc.Follea International Limited; Daniel Alain, Inc.Not yet recruitingChemotherapy Side Effects | Chemotherapy Induced AlopeciaItaly, Brazil
-
Applied Biology, Inc.Follea International Limited; Daniel Alain, Inc.Not yet recruitingChemotherapy Side Effects | Chemotherapy Induced AlopeciaItaly, Brazil
-
Case Comprehensive Cancer CenterVelaSanoRecruitingChemotherapy-induced Peripheral Neuropathy | CIPN - Chemotherapy-Induced Peripheral NeuropathyUnited States
-
Koç UniversityThe Scientific and Technological Research Council of TurkeyCompletedChemotherapyTurkey (Türkiye)
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingChemotherapy-Induced Peripheral Neuropathy | Paclitaxel-Induced Peripheral Neuropathy | Refractory Chemotherapy-Induced Peripheral Neuropathy
-
Cairo UniversityKafrelsheikh UniversityRecruiting
-
Pomeranian Medical University SzczecinZealand University Hospital; University Medicine Greifswald; University Clinical... and other collaboratorsRecruitingCancer | Chemotherapy | Chemotherapy-induced Neutropenia | Cancer-related Problem/Condition | Chemotherapy Induced Thrombocytopenia | Chemotherapy Induced AnaemiaGermany, Denmark, Poland
-
Zhejiang Cancer HospitalRecruitingIBI363 + ChemotherapyChina